Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

ACCELERON PHARMA INC.

(XLRN)
uitgestelde koers. Vertraagde tijd Nasdaq - 19/11 22:00:00
178.75 USD   -0.52%
22/11Merck rondt overname Acceleron Pharma af
MT
22/11Merck rondt overnamebod in contanten op Acceleron Pharma af voor $180/aandeel
MT
17/11Merck breidt overnamebod op Acceleron Pharma uit
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op ACCELERON PHARMA INC.
03/12Bristol Myers Squibb Gets FDA Acceptance of sBLA for Reblozyl
22/11ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from NASDAQ Biotechnology Index
22/11ACCELERON PHARMA : Completion of Acquisition or Disposition of Assets - Form 8-K
22/11ACCELERON PHARMA INC : Completion of Acquisition or Disposition of Assets, Notice of Delis..
22/11MERCK : l'acquisition d'Acceleron est finalisée
22/11Merck Completes Acceleron Pharma Acquisition
22/11Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.
22/11Merck Completes Cash Tender Offer to Purchase Acceleron Pharma at $180/Share
22/11ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from S&P Biotechnology Select Industry Inde..
22/11ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from S&P Global BMI Index
22/11ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from S&P TMI Index
22/11ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from NASDAQ Composite Index
20/11Merck Completes Tender Offer to Acquire Acceleron Pharma Inc
19/11Merck Sharp & Dohme Corp. completed the acquisition of Acceleron Pharma Inc. from Avoro..
17/11Avoro Capital Urges Acceleron Shareholders Not to Tender Into Merck's 'Inadequate' Offe..
17/11Avoro Capital Urges Acceleron Shareholders Not to Tender Into Merck's Inadequate Offer
17/11MERCK : l'OPA sur Acceleron va être prolongée
17/11Merck Extends Tender Offer for Acceleron Pharma
09/11Avoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Ten..
04/11Acceleron Reports Third Quarter 2021 Financial Results - Form 8-K
04/11ACCELERON : Q3 Earnings Snapshot
04/11ACCELERON PHARMA INC Management's Discussion and Analysis of Financial Condition and R..
04/11Acceleron Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
04/11Acceleron Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
04/11Earnings Flash (XLRN) ACCELERON PHARMA Reports Q3 Loss $-0.95
04/11Acceleron Reports Third Quarter 2021 Financial Results
02/11SHAREHOLDER ALERT : WeissLaw LLP Reminds DWSN, PAE, XLRN, and FLXN Shareholders About Its ..
01/11Merck Announces Withdrawal and Refiling under the Hart-Scott-Rodino Act and Extension o..
01/11MORNING BRIEFING - USA/Asien -2-
31/10WOCHENEND-ÜBERBLICK Unternehmen/30. und 31. Oktober 2021
31/10Andienungsfrist für Merck-Angebot an Acceleron-Aktionäre verlängert sich
29/10Merck Extends FTC Review Period for Acceleron Buyout
28/10Merck prevé hasta 7.000 millones de dólares en ventas del medicamento COVID-19 hasta fi..
28/10Avoro Capital Issues Open Letter to Fellow Acceleron Pharma Shareholders
27/10Acceleron Pharma Sees Q3 Reblozyl Royalty Revenue at $32 Million Based on Net Sales of ..
27/10ACCELERON PHARMA INC : Results of Operations and Financial Condition (form 8-K)
27/10Acceleron Announces Third Quarter 2021 REBLOZYLģ Net Sales
27/10Acceleron Pharma Inc. Provides Revenue Guidance for the Third Quarter Ended September 3..
21/10MERCK : Bristol-Myers To Shed Acceleron Stake Ahead Of Merck & Co.'s $11.5 Billion Acquisi..
18/10ACCELERON PHARMA ALERT : Investors Should Contact Bragar Eagel & Squire, P.C. Over Tender ..
14/10MERCK : Acceleron Pharma Shareholder Says Merck & Co.'s Offer Significantly Undervalues Co..
13/10SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Acceleron Pha..
13/10ACCELERON PHARMA : Holocene Advisors says Merck's offer undervalues Acceleron
13/10ACCELERON PHARMA : Holocene Advisors says Merck's offer undervalues Acceleron
12/10MERCK : Launches Tender Offer to Buy Acceleron Pharma at $180 Per Share
12/10MERCK : lancement d'une OPA sur Acceleron Pharma
06/10PLANÈTE BOURSE : La revue de presse du mercredi 6 octobre 2021
06/10PRESSESPIEGEL/Unternehmen
04/10ANALYSE/Mercks neues Covid-19-Mittel ist Segen für den Markt
02/10ACCELERON INVESTOR ALERT BY THE FORM : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
01/10SHAREHOLDER INVESTIGATION : Halper Sadeh LLP Investigates XLRN, ADTN, DSPG, KDMN; Sharehol..
01/10Autumn cold snap
01/10ANALYST RECOMMENDATIONS : Acceleron Pharma, General Mills, Southwest Airlines, Home Depot,..
01/10MERCK : le rachat d'Acceleron Pharma est scellé
01/10PLANÈTE BOURSE : La revue de presse du vendredi 1er octobre 2021
01/10NORTH AMERICAN MORNING BRIEFING : Fears Heighten -2-
01/10MERCK : to Buy Rare Disease Specialist Acceleron for $11.5 Billion
30/09Merck to buy Acceleron for about $11.5 billion in rare disease drug push
30/09Health Care Down, But Not By Much, As Deal Activity Cushions Losses - Health Care Round..
30/09Avoro Capital Discloses its Views on Proposed Acquisition of Acceleron Pharma to Merck ..
30/09ACCELERON PHARMA : Avoro Capital Believes Proposed Acquisition of Acceleron Pharma by Merc..
30/09Health Care Stocks Closing Slightly Lower After Early Gains
30/09ACCELERON MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whether the..
30/09Health Care Stocks Unable to Sustain Early Rise
30/09SHAREHOLDER ALERT : Ademi LLP investigates whether Acceleron Pharma Inc. has obtained a Fa..
30/09Markets take a breather after the purge
30/09MERCK : to Buy Acceleron for $11.5 Billion, or $180 Per Share in Cash, to Expand Cardiovas..
30/09ACCELERON PHARMA : Merck spends $11.5B for Acceleron, possible blockbuster drug
30/09Le laboratoire Merck & Co rachète Acceleron pour 11,5 milliards
30/09Health Care Stocks Gain Premarket Thursday
30/09Les valeurs à suivre aujourd'hui à Wall Street Jeudi 30 septembre 2021
30/09MERCK : rachète Acceleron Pharma
30/09ACCELERON PHARMA : REBLOZYLģ (luspatercept-aamt) is a First-In-Class Erythroid Maturation ..
30/09Merck to Buy Acceleron Pharma for $11.5 Billion
30/09Merck & Co will Acceleron Pharma kaufen - Bewertung etwa 11,5 Milliarden Dollar
1  2  3  4  5  6  7  8  9Volgende
Volgende evenement op ACCELERON PHARMA INC.
02/03/22